IndraLab

Statements



reach
"BX795 has been shown previously to block IRF3 activation and transcription but did not block NF-kappa B signalling in response to TLR3 or TLR4 agonists."

reach
"Because BX795 completely prevents Alpinone-dependent upregulation of IFNa and IRF3, the flavonoid targets seem to be upstream of the kinases TBK1 and IKKε."

reach
"BAY11-7082 inhibits NF-κB expression by blocking IκBα phosphorylation, while BX795 inhibits IRF3 activation by blocking the catalytic activities of Tank-binding kinase 1 (TBK1) and IκB kinase ε (IKKε) (37)."

reach
"Inhibition of IRF3 activation by BX795 in HepG2 and C3A cells prevented synthesis of interferon stimulated genes and improved HEV replication in these cells."

reach
"Our experiments revealed that BX795 reversed the apoptosis of OV-90 cells and inhibited the activation of IRF-3 induced by reovirus dsRNA."

reach
"BX795, an inhibitor of TBK1 and IKKepsilon, inhibited the activation of IRF3 (XREF_FIG, 4 th lane), and restored the inhibition of TGF-beta-induced transcription by TpIC (XREF_FIG, lanes 3, 4)."

reach
"First, we pretreated MDMs with BX795, which potently blocks IRF3 activation and interferon production through inhibition of the IKK related kinases TANK binding kinase 1 and IKKepsilon."